Drug Profile
Polaprezinc - Zeria
Alternative Names: Aprozinate; Aprozinato; Promac; Z 103; ZC 103; Zinc L-carnosineLatest Information Update: 11 Apr 2021
Price :
$50
*
At a glance
- Originator Hamari Chemicals
- Developer SK Chemicals; Zeria
- Class Antiulcers; Cytoprotectives; Neuropeptides; Organometallic compounds; Small molecules
- Mechanism of Action Lipid peroxidation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Gastric ulcer
- No development reported Gastritis
- Discontinued Taste disorders
Most Recent Events
- 11 Apr 2021 Discontinued - Phase-III for Taste disorders in Japan (PO, Granules)
- 11 Apr 2021 Discontinued - Phase-III for Taste disorders in Japan (PO, Tablet)
- 18 Mar 2015 No recent reports on development identified - Registered for Gastritis and Gastric ulcer in South Korea (PO)